JAUNDICE DUE TO HEPATIC LIPIDOSIS FELINE IMMUNODEFICIENCY VIRUS IN CATS

  • Ni Luh Putu Yunita Listiana Dewi Praktisi Dokter Hewan, Jl. By Pass Ngurah Rai Gg. Karang No. 8, Tuban, Kuta, Bali, Indonesia 80361
  • I Nyoman Suartha Laboratorium Ilmu Penyakit Dalam Veteriner, Fakultas Kedokteran Hewan Universitas Udayana, Jl. Raya Sesetan Gg. Markisa No. 6, Denpasar Selatan, Bali, Indonesia
  • I Gusti Made Krisna Erawan Laboratorium Ilmu Penyakit Dalam Veteriner, Fakultas Kedokteran Hewan Universitas Udayana, Jl. Raya Sesetan Gg. Markisa No. 6, Denpasar Selatan, Bali, Indonesia

Abstract

Feline Immunodeficiency Virus (FIV) is a disease caused by a virus that attacks the cat's immune system. Feline Hepatic Lipidosis (FHL) is the most common liver disease in cats caused by excessive accumulation of triglycerides in hepatocytes which causes cholestasis liver dysfunction. This case study aims to find out how to diagnose treat cases of jaundice in cats. A Himalayan cat aged 7 years weighing 3.3 kg was examined at the Listriani Vetcare Clinic in a weak condition. Previously, the cat was missing for 50 days was later found in a neighbor's barn where there was only rainwater seepage. On physical examination, jaundice was found on the ears, sclera, lips, abdomen, abdominal distention was observed. Hematology examination was performed twice on day 2 day 9, blood chemistry, ultrasonography, FIV/FelV test kit. Hematological examination on the 2nd day showed that the case cat had mild anemia, leukopenia, neutropenia, thrombocytopenia. The 9th day hematological examination showed anemia, neutrophilia, thrombocytopenia. Blood chemistry results showed an increase in alkaline phospatase, alanine aminotransferase, gamma-glutamyl transferase, total bilirubin, bile acids, total cholesterol, a decrease in Blood Urea Nitrogen. Ultrasound of the liver showed a diffuse hyperechoic mass the FIV/FelV test kit was FIV positive. Based on anamnesis, clinical examination, laboratory tests, the case cat was diagnosed with hepatic lipidosis FIV with a dubious prognosis. Case cats were treated with Cefotaxime (20 mg/kg, IV, three times a day), Hematodin® (0,6 mL, IV, once a day), Ondansetron (0,2 mg/kg, IV, twice a day), Samylin® small (1 tab, once a day), Metronidazole (25 mg/kg BW, PO, twice a day) for 10 days, Urdafalk (15 mg/kg BW, PO, once a day), Lactulose® (3 mL, PO, three times a day). On the 5th day, ondansetron cefotaxime were stopped given Cephalexin (38 mg/kg BW, PO, twice a day), Iron (1 tab, PO once a day), vitamin B12 (0.2 mL IV) TF Advance® (1 capsule, twice a day). The treatment given did not improve the condition, the case cat died on the 13th day. It is recommended that owners do not provide access for cats to leave the house to reduce the possibility of cats getting lost or contact with other cats that can transmit disease.

Downloads

Download data is not yet available.

References

Brown B, Mauldin GE, Armstrong J, Moroff SD, Mauldin GN. 2000. Metabolic Hormonal
Alterations in Cats with Hepatic Lipidosis. J. Vet. Internal Med. 14: 20–26
Center SA. 2005. Feline Hepatic Lipidosis. Vet. Clinics Small Anim. Pract. 35: 225269
Center SA. 2016. Feline Hepatic Lipidosis. MSD Manual. Departement of Clinical Science. Cornell University.
Da Costa FVA, Valle SF, Machado G, Corbellini LG. 2017. Hematological findings factors associated with feline leukemia virus (FeLV) feline immunodeficiency virus (FIV) positivity in cats from southern Brazil. Pesquisa Vet. Bras. 37(12): 15311536. de Rozieres S, Mathiason CK, Rolston MR, Chatterji U, Hoover EA Elder JH. 2004. Characterization of a highly pathogenic Mol. clone of feline immunodeficiency virus clade C. J. Virol. 78(17): 8971–8982.
Ettinger SJ, Feldman EC. 2000. Textbook of Vet. Internal Med.―Diseases of the Dog Cat. 2nd Edition, WB Saunders Co., Philadelphia, Pp. 402-406.
Hartmann K. 2011. Clinical aspects of feline immunodeficiency feline leukemia virus infection. Vet. Immunol Immunopathol. 143: 190-201.
Heo SH, Yoon YM, Hwang TS, Jung DI, Lee HC. 2018. Imaging diagnosis of hepatic lipidosis in a cat. Korean J. Vet. Res. 58(2): 99-101
Hosie MJ, Addie D, Belak S, Boucraut-Baralon C, Egberink H, Frymus T, Gruffydd-Jones T,
Hartmann K, Lloret A, Lutz H, Marsilio F, Pennisi MG, Radford AD, Thiry E, Truyen
U, Horzinek MC. 2009. Feline Immunodeficiency: ABCD Guidelines on Prevention Management. J. Feline Med. Surg. 11: 575-584.
Javinsky E. 2012. Hematology Immune-Related Disorders. The Cat: Clin. Med. Manag. 25: 643-703.
Kanzaki LIB, Looney DJ. 2004. Feline Immunodeficiency Virus: A Concise Review. Front. Biosci. 9: 370-377.
Kuzi S, Segev G, Kedar S, Yas E, Aroch I. 2017. Prognostic markers in feline hepatic lipidosis: a retrospective study of 71 cats. Vet. Rec. 181(19): 1-8
Manzoor A, Zafar MA, Ijazl M, Raza A, Ahmed M. 2012. Use of Chellidonium® (A Homeopathic Med.) for the Treatment of Icterus in Cats. Int. J. Mol. Vet. Res. 2(7): 25-28.
Olson SW, Hohenhaus AE. 2019. Feline Non-Regenerative Anemia Diagnostic treatment recommendations. J. Feline Med. Surg. 21: 615–631
Putri ZU, Sulistiawati E, Sajuthi D. 2018. Persentase Kejadian Hiperbilirubinemia pada Kucing. Proceedings of the 20th FAVA CONGRESS & the 15th KIVNAS PDHI 1(3): 316-318
Sherding RG. 2000. Feline Jaundice. J. Feline Med. Surg. 2: 165–169.
Tvedten HW. 1981. Hematology of the normal dog cat. Vet. Clin. North Am. Small Anim. Pract. 11(2): 209-217.
Valtolina C, Favier RP. 2017. Feline Hepatic Lipidosis. Vet. Clinics Small Anim. 47: 683–702
Webb CB. 2016. The Yellow Cat: Diagnostic & Therapeutic Strategies. Today’s Vet. Pract. Pp. 38-50.
Webb CB. 2018. Hepatic Lipidosis Clinical review drawn from collective effort. J. Feline Med. Surg.20: 217–227.
Published
2023-05-14
How to Cite
LISTIANA DEWI, Ni Luh Putu Yunita; SUARTHA, I Nyoman; ERAWAN, I Gusti Made Krisna. JAUNDICE DUE TO HEPATIC LIPIDOSIS FELINE IMMUNODEFICIENCY VIRUS IN CATS. Buletin Veteriner Udayana, [S.l.], p. 1150-1158, may 2023. ISSN 2477-2712. Available at: <https://ojs.unud.ac.id/index.php/buletinvet/article/view/93944>. Date accessed: 21 nov. 2024. doi: https://doi.org/10.24843/bulvet.2023.v15.i06.p14.
Section
Articles

Most read articles by the same author(s)